Nextremity Solutions, LLC announced it has obtained first-in-man implants for its Nextra Hammertoe Correction System. The Nextra System is a key component to the company’s forefoot reconstruction portfolio and will be introduced for limited release at the American Orthopaedic Foot & Ankle Society Congress, July 13-15 in Keystone, Colorado. Nextremity Solutions co-founder, Dr. Stuart Katchis, MD commented after two patients were successfully impIanted with the Nextra Hammertoe Correction Implant. He noted, “The ability to maintain accurate and stable alignment of the PIP joint during hammertoe correction surgery is essential to gaining consistent correction and fusion of that joint. The Nextra implant used in these cases demonstrated ease of insertion and the ability to fix the bones in a stable and accurate position. Two month follow-up showed fusion of the joint was achieved and the patients’ pain resolved.” Dr. Lon Weiner, Nextremity Solutions co-founder, commented that, “These initial surgical procedures mark an important milestone for Nextremity Solutions. There has been interest among surgeons for a hammertoe device that could provide consistently good results. The precision through adjustability and reversibility offers surgeons that opportunity. We look forward to working closely with podiatric and orthopaedic surgeons in the limited release phase of the commercialization of the Nextra Hammertoe Correction System.” About Nextremity Solutions, LLC Nextremity Solutions is a privately held medical-device company offering a novel approach to the surgical correction of small bone deformity, degeneration and trauma. Nextremity Solutions was founded by surgeons who are committed to the development of medical implants that will provide repeatably superior patient outcomes. Nextra™ Hammertoe Correction System and Nextra™ Hammertoe Correction Implant are trademarks of Nextremity Solutions, LLC. For further information, visit www.nextremitysolutions.com or call 574-635-3023.
